Int J Thyroidol.
2019 May;12(1):70-70. 10.11106/ijt.2019.12.1.70.
Corrigendum: Adverse Events of Tyrosine Kinase Inhibitors in Patients with Advanced Thyroid Cancer
- Affiliations
-
- 1Department of Internal Medicine, Seoul National University Hospital, Seoul, Korea.
- 2Department of Internal Medicine, Healthcare Research Institute, Seoul National University Hospital Healthcare System Gangnam Center, Seoul, Korea.
- KMID: 2449069
- DOI: http://doi.org/10.11106/ijt.2019.12.1.70
Abstract
- There are some errors in the published article.
- Full Text Links
-
- Actions
-
Cited
- CITED
-
- Close
- Share
-
- Similar articles
-
- Adverse Events of Tyrosine Kinase Inhibitors in Patients with Advanced Thyroid Cancer
- Management of Severe Fatigue Induced by Tyrosine Kinase Inhibitor in Radioiodine Refractory Thyroid Cancer
- Management of Bleeding Induced by Tyrosine Kinase Inhibitor in Radioiodine Refractory Thyroid Cancer
- Skin-Related Toxicity of Tyrosine Kinase Inhibitor in Thyroid Cancer
- Current Status and Future Perspective of the Treatment for Radioiodine Refractory Differentiated Thyroid Cancer
